Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
M1 Kliniken AGMKLNF 92 EV-to-EBITDA is 8.43 as of Aug. 11, 2026, which is 32% below its 10-year median of 12.40. GuruFocus rates MKLNF with a GF Score™ of 92/100 and a GF Value™ of $9.78. The stock has 3 warning signs investors should review. Among 99 Medical Distribution companies, M1 Kliniken AG ranks better than 50.51% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, M1 Kliniken AG's enterprise value is $396.8 Mil.
M1 Kliniken AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $47.1 Mil. Therefore, M1 Kliniken AG's EV-to-EBITDA for today is 8.43.
The historical rank and industry rank for M1 Kliniken AG's EV-to-EBITDA or its related term are showing as below:
MKLNF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.83 Med: 12.4 Max: 33.14
Current: 8.68
During the past 12 years, the highest EV-to-EBITDA of M1 Kliniken AG was 33.14. The lowest was 3.83. And the median was 12.40.
MKLNF's EV-to-EBITDA is ranked better than 50.51% of 99
companies
in the Medical Distribution industry
Industry Median: 8.52
vs MKLNF: 8.68
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
M1 Kliniken AG (OTCPK:MKLNF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
M1 Kliniken AG's PE Ratio (TTM) for today is calculated as:
M1 Kliniken AG's share price for today is $11.7284.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. M1 Kliniken AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $1.382.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for M1 Kliniken AG's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, M1 Kliniken AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's EV-to-EBITDA falls into.
M1 Kliniken AG's current Enterprise Value is $396.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. M1 Kliniken AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $47.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M1 Kliniken AG (MKLNF) has a EV-to-EBITDA of 8.43 as of Aug. 11, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on M1 Kliniken AG. This is 32% below median its historical median of 12.40. Over the past decade, M1 Kliniken AG's EV-to-EBITDA has ranged from 3.83 to 33.14. According to the industry distribution chart, M1 Kliniken AG ranks #49 out of 99 companies in the Medical Distribution industry, placing it in the top 49.5%.
Is M1 Kliniken AG's EV-to-EBITDA too high?
M1 Kliniken AG's current EV-to-EBITDA of 8.43 is 32% below median its 10-year median of 12.40. Over the past 10 years, this metric has ranged from a low of 3.83 to a high of 33.14. The Medical Distribution industry median EV-to-EBITDA is 8.52. M1 Kliniken AG's value of 8.43 is 1.1% below this industry median. Based on the distribution chart, M1 Kliniken AG ranks #49 out of 99 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, M1 Kliniken AG has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's EV-to-EBITDA compare to MCK and COR?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #49 out of 99 companies for EV-to-EBITDA. This puts M1 Kliniken AG in the upper half of its industry. The industry median EV-to-EBITDA is 8.52. M1 Kliniken AG's value of 8.43 is 1.1% below this benchmark. Historically, M1 Kliniken AG's own EV-to-EBITDA has ranged from 3.83 to 33.14 over the past decade. While the company's 10-year median is 12.40 vs. the industry median of 8.52, M1 Kliniken AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.52, based on 99 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M1 Kliniken AG's current EV-to-EBITDA of 8.43 is 1.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on M1 Kliniken AG. For the Medical Distribution industry, the median EV-to-EBITDA is 8.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M1 Kliniken AG's current EV-to-EBITDA is 8.43, which is 32% below median its own 10-year median of 12.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
M1 Kliniken AG (MKLNF) has a current EV-to-EBITDA of 8.43. The stock's GF Value™ is $9.78, compared to a current price of $11.73 — trading 19.9% above its estimated fair value. The current EV-to-EBITDA is 8.43, which is 32% below median its 10-year median of 12.40 and 1.1% below the Medical Distribution industry median of 8.52. M1 Kliniken AG's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For M1 Kliniken AG (MKLNF), the current EV-to-EBITDA is 8.43 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (MKLNF) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of $11.73 is trading 19.9% above its estimated GF Value™ of $9.78.
Key valuation signals for MKLNF:
EV-to-EBITDA: 8.43 (32% below median its 10-year median of 12.40)
GF Value™: $9.78 vs. price of $11.73 (19.9% above fair value)
Industry Position: 1.1% below the Medical Distribution median (#49 of 99)
No single metric tells the full story. See the MKLNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
92GF Score
Get the complete analysis for MKLNF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MKLNF has been successfully added to your 
